Pharma/Biotech – Asia, ROW Regulatory News, April 2023 Vol. 2
ASIA
MALAYSIA (NPRA)
Declaration of Worldwide Registration Status for Generic Medicines
Malaysia now requires all new applications for Generic Medicines (Prescription – Full) to include...
ANVISA, Asia Regulatory News, BioTech, Chemistry, eCTD, Manufacturing and Control (CMC), Pharma, Regulatory Updates, ROW Regulatory News